Opendata, web and dolomites

DUBs26S SIGNED

Role of a novel proteasome-associated DUB – A boon for therapeutics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DUBs26S project word cloud

Explore the words cloud of the DUBs26S project. It provides you a very rough idea of what is the project "DUBs26S" about.

subunit    myriad    opens    networking    extraordinarily    proposing    training    notion    interaction    action    spheres    job    investigation    drug    enzyme    ubiquitin    enzymes    drugable    clearing    live    proteasome    deubiquitinating    phyla    replacing    goals    processivity    l5    unravel    fruition    basic    disposal    respective    reported    healthy    redundant    committed    structure    preparation    tweaks    proposes    site    competencies    cancers    shatters    multisubunit    researcher    active    efforts    labs    usp9x    cells    msc    conserved    experimental    dubs    fixed    relevance    expanded    career    embark    subset    purified    embellished    tools    applicative    reciprocal    usp14    relationship    fits    26s    ensures    clinically    complexes    instigate    clinical    composition    independent    incorporation    eukaryotic    enzymatic    alter    largely    msca    neurodegeneration    host    search    association    static    crux    realign    fact    specificity    proteins    tissue    dub    substrate    span    strategies    life    uch    found    human   

Project "DUBs26S" data sheet

The following table provides information about the project.

Coordinator
TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY 

Organization address
address: SENATE BUILDING TECHNION CITY
city: HAIFA
postcode: 32000
website: www.technion.ac.il

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 182˙509 €
 EC max contribution 182˙509 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-11-01   to  2019-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY IL (HAIFA) coordinator 182˙509.00

Map

 Project objective

Clearing-up old or redundant proteins is essential for cells to live; this job is largely done by 26S Proteasome. The multisubunit complex – 26S Proteasome – is extraordinarily conserved throughout all eukaryotic phyla, in terms of subunit composition and overall structure. However, in preparation of this research proposal, the Researcher found a novel association of 26S proteasome with a clinically important deubiquitinating enzyme (DUB), USP9X. In a subset of proteasome purified from human tissue by the Researcher, USP9X was in fact the major DUB replacing commonly reported enzymes (USP14, UCH-L5). This finding shatters the notion of proteasome as a static, fixed, complex, and opens up the search for expanded spheres of interaction. The crux of this MSC-IF action is the reciprocal relationship between 26S proteasome and USP9X. Using myriad experimental tools at his disposal, the Researcher proposes to unravel how this novel association tweaks each of their respective enzymatic properties. Incorporation of USP9X may alter substrate specificity and processivity of proteasome, as well as its own enzymatic properties. Even in the immediate term, this proposal will realign research efforts – both basic and applicative – towards USP9X as the new drugable target in the ubiquitin-proteasome system. This new enzymatic active site on proteasome complexes will instigate investigation into the cause of USP9X in neurodegeneration and various cancers. This MSCA-IF fits current European challenges to increase healthy life span by proposing strategies for drug design against DUBs of clinical relevance. Two host labs are committed to provide the Researcher with the best training and support to bring his research to fruition and embark his independent career. Novel experimental findings embellished with new technical competencies and networking experience ensures the Researcher’s future career goals.

 Publications

year authors and title journal last update
List of publications.
2019 Indrajit Sahu, Sachitanand M Mali, Prasad Sulkshane, Andrey Rozenberg, Cong Xu, Roni Morag, Manisha Priyadarsini Sahoo, Sumeet K Singh, Zhanyu Ding, Yifan Wang, Sharleen Day, Yao Cong, Oded Kleifeld, Ashraf Brik, Michael H Glickman
Signature activities of 20S proteasome include degradation of the ubiquitin-tag with the protein under hypoxia
published pages: , ISSN: , DOI: 10.1101/2019.12.20.883942
BioRxIV 2020-01-29
2019 Zhanyu Ding, Cong Xu, Indrajit Sahu, Yifan Wang, Zhenglin Fu, Min Huang, Catherine C.L. Wong, Michael H. Glickman, Yao Cong
Structural Snapshots of 26S Proteasome Reveal Tetraubiquitin-Induced Conformations
published pages: , ISSN: 1097-2765, DOI: 10.1016/j.molcel.2019.01.018
Molecular Cell 2019-05-15

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DUBS26S" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DUBS26S" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

RAMBEA (2019)

Realistic Assessment of Historical Masonry Bridges under Extreme Environmental Actions

Read More  

RegARcis (2020)

Role of the SWI/SNF complex in the Androgen Receptor cistrome regulation

Read More  

IRF4 Degradation (2019)

Using a novel protein degradation approach to uncover IRF4-regulated genes in plasma cells

Read More